312 records matched your query
02169aam a2200409Ia 4500 001 8133A7926B5411E69AFE1DDBDAD10320 003 SILO 005 20160826010517 008 121011s2012 dcua b 000 0 eng d 020 $a 0309253152 020 $a 9780309253154 035 $a (OCoLC)812530045 040 $a AAA $b eng $c AAA $d NDD $d OCLCQ $d UPM $d NRZ $d CDX $d IWA $d SILO 043 $a n-us--- 245 00 $a Envisioning a transformed clinical trials enterprise in the United States : $b establishing an agenda for 2020 : workshop summary / $c Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy, Institute of Medicine of the National Academies. 260 $a Washington, D.C. : $b National Academies Press, $c c2012. 300 $a xvi, 232 p. : $b ill. (some col.) ; $c 23 cm. 505 0 $a Introduction -- Integrating community practice and clinical trials -- Improving public participation in clinical trials -- Creating a new business model for clinical trials -- Building an infrastructure to support clinical trials -- Suggesting an agenda for transforming elements of the clinical trials enterprise. 504 $a Includes bibliographical references. 530 $a Also available online. 650 0 $a Clinical trials $z United States. 650 0 $a Clinical trials $x Economic aspects $z United States. 650 0 $a Clinical trials $x Social aspects $z United States. 650 0 $a Drug development $z United States. 650 0 $a Drugs $x Testing. 650 0 $a Pharmaceutical industry $z United States. 650 0 $a Business and medicine $z United States. 700 1 $a Weisfeld, Neil E. 700 1 $a English, Rebecca A. 700 1 $a Claiborne, Anne B. 710 2 $a Institute of Medicine (U.S.). $b Forum on Drug Discovery, Development, and Translation. 710 2 $a Institute of Medicine (U.S.). $b Board on Health Sciences Policy. 856 41 $u http://www.nap.edu/catalog.php?record_id=13345 941 $a 1 952 $l USUX851 $d 20160826061056.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=8133A7926B5411E69AFE1DDBDAD10320 994 $a C0 $b IWAInitiate Another SILO Locator Search